Department of Medical Genetics, Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, 330 University Ave., Moncton, NB, E1C 2Z3, Canada.
Atlantic Cancer Research Institute, Moncton, NB, Canada.
BMC Med Genomics. 2022 Apr 29;15(1):98. doi: 10.1186/s12920-022-01249-1.
Founder populations that have recently undergone important genetic bottlenecks such as French-Canadians and Ashkenazi Jews can harbor some pathogenic variants at a higher carrier rate than the general population, putting them at a higher risk for certain genetic diseases. In these populations, there can be considerable benefit to performing ethnic-based or expanded preconception carrier screening, which can help in the prevention or early diagnosis and management of some genetic diseases. Acadians are descendants of French immigrants who settled in the Atlantic Coast of Canada in the seventeenth century. Yet, the Acadian population has never been investigated for the prevalence/frequency of disease-causing genetic variants.
An exome sequencing panel for 312 autosomal recessive and 30 X-linked diseases was designed and specimens from 60 healthy participants were sequenced to assess carrier frequency for the targeted diseases.
In this study, we show that a sample population of Acadians in South-East New Brunswick harbor variants for 28 autosomal recessive and 1 X-linked diseases, some of which are significantly more frequent in comparison to reference populations.
Results from this pilot study suggests a need for further investigation of genomic variation in this population and possibly implementation of targeted carrier and neonatal screening programs.
最近经历过重要遗传瓶颈的创始人群体,如法裔加拿大人和阿什肯纳兹犹太人,其某些致病性变体的携带率可能高于一般人群,因此他们患某些遗传疾病的风险更高。在这些人群中,进行基于种族或扩展的孕前携带者筛查有很大的益处,可以帮助预防或早期诊断和管理某些遗传疾病。阿卡迪亚人是 17 世纪在加拿大大西洋沿岸定居的法国移民的后裔。然而,阿卡迪亚人群的致病基因突变体的流行率/频率从未被调查过。
设计了一个针对 312 种常染色体隐性和 30 种 X 连锁疾病的外显子组测序面板,并对 60 名健康参与者的样本进行了测序,以评估目标疾病的携带者频率。
在这项研究中,我们表明,新不伦瑞克省东南部的阿卡迪亚人样本人群携带有 28 种常染色体隐性和 1 种 X 连锁疾病的变体,其中一些与参照人群相比明显更为常见。
这项初步研究的结果表明,有必要进一步调查该人群的基因组变异情况,并可能实施有针对性的携带者和新生儿筛查计划。